BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481957. A total of 1 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | +42.9% | 80 | +12.7% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 71 | +86.8% | 0.00% | – |
| Q2 2019 | $6,000 | -77.8% | 38 | -53.7% | 0.00% | – |
| Q1 2019 | $27,000 | +575.0% | 82 | +412.5% | 0.00% | – |
| Q4 2018 | $4,000 | -81.8% | 16 | -55.6% | 0.00% | – |
| Q3 2018 | $22,000 | -71.4% | 36 | -65.7% | 0.00% | – |
| Q2 2018 | $77,000 | +126.5% | 105 | -33.5% | 0.00% | -100.0% |
| Q1 2018 | $34,000 | -44.3% | 158 | -0.6% | 0.00% | -66.7% |
| Q4 2017 | $61,000 | +41.9% | 159 | +6.7% | 0.00% | +50.0% |
| Q3 2017 | $43,000 | +104.8% | 149 | -37.7% | 0.00% | +100.0% |
| Q2 2017 | $21,000 | +110.0% | 239 | +37.4% | 0.00% | – |
| Q1 2017 | $10,000 | -83.3% | 174 | +79.4% | 0.00% | -100.0% |
| Q4 2016 | $60,000 | -42.3% | 97 | -81.3% | 0.00% | -42.9% |
| Q3 2016 | $104,000 | +333.3% | 519 | +265.5% | 0.01% | +250.0% |
| Q2 2016 | $24,000 | +2300.0% | 142 | +647.4% | 0.00% | – |
| Q1 2016 | $1,000 | -95.0% | 19 | -82.1% | 0.00% | -100.0% |
| Q4 2015 | $20,000 | +233.3% | 106 | +73.8% | 0.00% | – |
| Q3 2015 | $6,000 | – | 61 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 325 | $472,000 | 0.02% |
| Citadel Advisors | 700 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 61 | $6,000 | 0.00% |